dmc2

Kleanthis G. Xanthopoulos, Ph.D.

Kleanthis G. Xanthopoulos, Ph.D.

Kleanthis G. Xanthopoulos, Ph.D.

President & CEO

back
  • Former Founding CEO of Regulus Therapeutics (NASDAQ:RGLS)
  • Founder and Director of Sente Inc.
  • Managing Director at Enterprise Partners, Venture Capital
  • Former Founder and CEO at Anadys Pharma acquired by Roche for $230M
  • M.Sc. Ph.D. in Molecular Biology from Stockholm
  • Associate Professor of Karolinska Institute, Stockholm, Sweden